No results found.
The major aim of this project is to address the involvement of mitochondria in Huntington’s disease. CIIMAR has been involved in the molecular tasks of the project, in particular in the study of the affected molecular pathway following exposure to pharmaceuticals impacting normal mitochondria functions.
